Last Updated: October 6, 2026

LIPIDIL Drug Patent Profile

Name: LIPIDIL Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Lipidil, and what generic alternatives are available?

Lipidil is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in LIPIDIL is fenofibrate. There is one drug master file entry for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lipidil

A generic version of LIPIDIL was approved as fenofibrate by RHODES PHARMS on May 13^th, 2005.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LIPIDIL?
What are the global sales for LIPIDIL?
What is Average Wholesale Price for LIPIDIL?

Summary for LIPIDIL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	5
Patent Applications:	4,322
Drug Prices:	Drug price information for LIPIDIL
DailyMed Link:	LIPIDIL at DailyMed

Drug patent expirations by year for LIPIDIL

Recent Clinical Trials for LIPIDIL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Chong Kun Dang Pharmaceutical	Phase 1
HK inno.N Corporation	Phase 1
CJ HealthCare Corporation	Phase 1

See all LIPIDIL clinical trials

US Patents and Regulatory Information for LIPIDIL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	LIPIDIL	fenofibrate	CAPSULE;ORAL	019304-001	Dec 31, 1993		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LIPIDIL

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	LIPIDIL	fenofibrate	CAPSULE;ORAL	019304-001	Dec 31, 1993	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LIPIDIL

See the table below for patents covering LIPIDIL around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Belgium	742484		⤷ Start Trial
Belgium	790026		⤷ Start Trial
Brazil	7016496		⤷ Start Trial
Canada	960670	PHENOXY-ALKYL-CARBOXYLIC ACID DERIVATIVES AND THE PREPARATION THEREOF	⤷ Start Trial
Switzerland	515873	Procédé de préparation de composés dérivés de l'acide phénoxy-alkyl-carboxylique (Phenoxyacetic acid derivs)	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.